Lv11
60 积分 2025-07-19 加入
Real-world experience with baseline characteristics and safety of lecanemab for Alzheimer's disease in Eastern China
1个月前
已完结
Multiple ischemic strokes in a patient treated with Lecanemab: a case report
1个月前
已完结
An International Working Group viewpoint on stratifying risk and prevention of the clinical expression of Alzheimer’s disease
3个月前
已完结
Neuropathology after active Aβ42 immunotherapy: implications for Alzheimer’s disease pathogenesis
3个月前
已完结
Spontaneous haemorrhage in subdural hygroma in an Alzheimer’s patient on lecanemab
4个月前
已完结
Comprehensive evaluation of plasma tau biomarkers for detecting and monitoring Alzheimer’s disease in a multicenter and multiethnic aging population
5个月前
已完结
Higher plasma soluble TREM2 correlates with reduced cerebral tau accumulation in Alzheimer’s disease
5个月前
已完结
Transferrin receptor–targeted anti-amyloid antibody enhances brain delivery and mitigates ARIA
5个月前
已完结
Lemborexant ameliorates tau-mediated sleep loss and neurodegeneration in males in a mouse model of tauopathy
6个月前
已完结
皖公网安备34019202002308
